Previous 10 | Next 10 |
NORWOOD, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) (“Corbus” or the “Company”), a precision oncology company with a diversified portfolio, today announced the pricing of an underwritten public offering of 4,325,000 sh...
2024-01-31 01:47:00 ET More on Corbus Pharmaceuticals Corbus: Ability To Have Best-In-Class Nectin-4 Targeting Drug Corbus Pharmaceuticals: Surging On The Back Of Great News, But I See Dark Clouds Corbus Pharma reverses gains on common stock offering Corbus P...
NORWOOD, Mass., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) (“Corbus” or the “Company”), a precision oncology company with a diversified portfolio, today announced that it plans to offer and sell shares of its common stock or,...
2024-01-30 11:50:46 ET Gainers: Neximmune ( NEXI ) +163% . Pixelworks ( PXLW ) +47% . PepGen ( PEPG ) +37% . Rail Vision Ltd ( RVSN ) +36% . Bit Origin Ltd ( BTOG ) +34% . Vivos Therapeutics ( VVOS ) +32% . GRI Bi...
2024-01-30 07:13:44 ET Summary Positive results released from phase 1 China study, using CRB-701 for the treatment of patients with metastatic urothelial carcinoma and other nectin-4 positive solid tumors. Trial initiation of phase 1 study, using CRB-701 for the treatment of patie...
2024-01-29 14:17:45 ET Summary Corbus Pharmaceuticals has experienced a surge in stock price after positive clinical results for their antibody drug conjugate, CRB-701. CRBP is conducting phase 1 studies for CRB-701 in patients with Nectin-4-positive solid tumors, showing favorabl...
2024-01-29 09:00:03 ET More on Corbus Pharmaceuticals Corbus Pharma surges after early Phase 1 data for tumor candidate Seeking Alpha’s Quant Rating on Corbus Pharmaceuticals Historical earnings data for Corbus Pharmaceuticals Financial information for...
2024-01-29 08:22:54 ET Losers: Panbela Therapeutics PBLA -63% on $9M public offering . Aclarion ( ACON ) -19% . Corbus Pharmaceuticals Holdings ( CRBP ) -21% it releases data for ADC Tumor candidate . Richtech Robotics ( RR ) -11% . ...
2024-01-29 07:18:08 ET The stock of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) closed up nearly 250% last week. The gains happened after favourable pharmaceutical news that saw the stock climb above $29. CRBP was previously trading at a meagre valuation below $7. Despite the st...
--News Direct-- New York, Jan. 29, 2024 - ( Plato Data ) -- Corbus Pharmaceuticals (NASDAQ:CRBP) jumped on Friday after announcing positive data from a small group of cancer patients who received its antibody-drug conjugate (ADC) CRB-701 in a Phase 1 trial. Citing a December d...
News, Short Squeeze, Breakout and More Instantly...
Corbus Pharmaceuticals Holdings Inc. Company Name:
CRBP Stock Symbol:
NASDAQ Market:
Corbus Pharmaceuticals Holdings Inc. Website:
2024-07-16 13:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
A look at the top 10 most actives in the United States Senti Biosciences Inc. (SNTI) rose 51.3% to $0.4175 on volume of 386,768,896 shares NVIDIA Corporation (NVDA) rose 0.6% to $124.3 on volume of 277,459,318 shares PROSHARES TRUST (SQQQ) fell 1.9% to $8.12 on volume of 139,088,335 share...